1. Home
  2. VRAX vs HIHO Comparison

VRAX vs HIHO Comparison

Compare VRAX & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • HIHO
  • Stock Information
  • Founded
  • VRAX 2013
  • HIHO 1990
  • Country
  • VRAX United Kingdom
  • HIHO Hong Kong
  • Employees
  • VRAX N/A
  • HIHO N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HIHO Industrial Machinery/Components
  • Sector
  • VRAX Health Care
  • HIHO Industrials
  • Exchange
  • VRAX Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • VRAX 4.4M
  • HIHO 7.6M
  • IPO Year
  • VRAX 2022
  • HIHO 1996
  • Fundamental
  • Price
  • VRAX $0.61
  • HIHO $1.68
  • Analyst Decision
  • VRAX Strong Buy
  • HIHO
  • Analyst Count
  • VRAX 1
  • HIHO 0
  • Target Price
  • VRAX $3.00
  • HIHO N/A
  • AVG Volume (30 Days)
  • VRAX 1.6M
  • HIHO 200.7K
  • Earning Date
  • VRAX 01-01-0001
  • HIHO 09-11-2025
  • Dividend Yield
  • VRAX N/A
  • HIHO 7.02%
  • EPS Growth
  • VRAX N/A
  • HIHO N/A
  • EPS
  • VRAX N/A
  • HIHO 0.01
  • Revenue
  • VRAX $6,331.00
  • HIHO $7,080,000.00
  • Revenue This Year
  • VRAX $217,274.83
  • HIHO N/A
  • Revenue Next Year
  • VRAX N/A
  • HIHO N/A
  • P/E Ratio
  • VRAX N/A
  • HIHO $177.06
  • Revenue Growth
  • VRAX N/A
  • HIHO 3.31
  • 52 Week Low
  • VRAX $0.52
  • HIHO $1.40
  • 52 Week High
  • VRAX $3.62
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 40.99
  • HIHO 49.23
  • Support Level
  • VRAX $0.54
  • HIHO $1.61
  • Resistance Level
  • VRAX $0.70
  • HIHO $1.77
  • Average True Range (ATR)
  • VRAX 0.06
  • HIHO 0.10
  • MACD
  • VRAX 0.01
  • HIHO -0.00
  • Stochastic Oscillator
  • VRAX 50.56
  • HIHO 25.00

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

Share on Social Networks: